Sales reps& bias lawsuit against Novartis to move forward

Share this article:

A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales employees in a $100 million class-action lawsuit.

Judge Gerald Lynch granted class-action status to a lawsuit in US District Court in Manhattan against Novartis by 19 current and former sales employees, according to published reports.

In his order, the judge also granted a request to dismiss claims against Novartis Corp., the pharmaceutical unit's parent.

The lawsuit, filed in 2004, alleged Novartis' pharma unit was discriminatory in its pay, promotions, evaluations and treatment of women who take pregnancy leave.

A Novartis spokesman said the company's lawyers just received the documents related to the lawsuit and were reviewing them.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.